LEXINGTON, Mass. and AMSTERDAM, Jan. 09, 2026 (GLOBE NEWSWIRE) -- uniQure N.V. (NASDAQ: QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs, ...
(RTTNews) - Outlook Therapeutics, Inc. (OTLK) announced that it recently held a Type A meeting with the U.S. FDA to discuss the Complete Response Letter (CRL) issued in December 2025 for its Biologics ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results